Non-Particulate Steroids (Betamethasone Sodium Phosphate, Dexamethasone Sodium Phosphate, and Dexamethasone Palmitate) Combined with Local Anesthetics (Ropivacaine, Levobupivacaine, Bupivacaine, and Lidocaine): A Potentially Unsafe Mixture
Eun Joo Choi,Dong-Hyun Kim,Woong Ki Han,Ho-Jin Lee,Imhong Kang,Francis Sahngun Nahm,Pyung-Bok Lee
DOI: https://doi.org/10.2147/JPR.S311573
IF: 2.8319
2021-05-27
Journal of Pain Research
Abstract:Eun Joo Choi, 1 Dong-Hyun Kim, 1 Woong Ki Han, 1 Ho-Jin Lee, 2 Imhong Kang, 3 Francis Sahngun Nahm, 1, 4 Pyung-Bok Lee 1, 4 1 Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea; 2 Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea; 3 Department of Anesthesiology and Pain Medicine, Bundang Chuk Hospital, Seongnam, Korea; 4 Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea Correspondence: Pyung-Bok Lee Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro 173 Beon-Gil, Bundang-Gu, Seongnam, 13620, Korea Tel +82-31- 787-7499 Fax +82-31- 787-4063 Email Purpose: Particulate steroids used in epidural steroid injections have been suspected as a cause of post-procedural embolic events. Some particulate steroids have been suspended only when the transforaminal approach is used for an epidural block of the spine. In contrast, non-particulate steroids are generally accepted for safety during epidural steroid injections. However, the safety of using a mixture of non-particulate steroids and local anesthetics is unknown. This study analyzed whether mixtures of commonly used non-particulate steroids and local anesthetics form crystals in solution. Methods: We mixed non-particulate steroids (betamethasone sodium phosphate, dexamethasone sodium phosphate, and dexamethasone palmitate) and local anesthetics (ropivacaine, levobupivacaine, bupivacaine, and lidocaine) at different ratios. We used fluorescence microscopy to observe whether crystals formed in mixed solutions; we also measured the pH of each steroid, local anesthetic, and the mixtures. Results: Ropivacaine or levobupivacaine and betamethasone sodium phosphate produced large crystals (> 50 μm). Ropivacaine or levobupivacaine and dexamethasone sodium phosphate produced small crystals (< 10 μm). Lidocaine and all non-particulate steroids produced no identifiable crystals; dexamethasone palmitate and all local anesthetics did not form significant particulates. Betamethasone sodium phosphate and dexamethasone sodium phosphate demonstrated basic pH, while all local anesthetics demonstrated acidic pH. Mixtures showed a wide pH range. Conclusion: Non-particulate steroids can form crystals upon combination with local anesthetics. Crystal formation may be caused by alkalinization of steroids. The mixing of ropivacaine or levobupivacaine and betamethasone sodium phosphate may require caution during an epidural steroid injection. Lidocaine or bupivacaine is recommended as a local anesthetic. Dexamethasone palmitate is a candidate for a mixture, but additional studies on its safety and effectiveness are needed. Keywords: epidural space, injections, lidocaine, local anesthetics, particle size, steroids Epidural steroid injection (ESI) is used for the treatment of spinal pain, and the number of treated cases has increased sharply. 1 However, questions remain regarding the effects and safety of different ESI approaches (eg, an interlaminar or transforaminal approach) or the use of specific drugs (eg, non-particulate steroids or particulate steroids). 2–6 In particular, the cause of catastrophic complications after ESI, such as cerebral or spinal cord infarct, as well as transient ischemic attack, 7–9 may be related to the injection of particulate steroids. Particulate steroids may work as an embolus if injected into spinal branches that have anastomosed with the vertebral artery; when cervical transforaminal ESI (TFESI) was performed, these embolic events were reported frequently. 7 , 9–11 These events attracted the attention of the US Food and Drug Administration (FDA); in April 2014, the FDA issued a warning of serious neurologic complications after ESI and implemented label changes. 12 , 13 The Anesthetic and Analgesic Advisory Committee was formed in November of the same year. This committee recommended a contraindication for transforaminal cervical injections with particulate steroids because of the concern of catastrophic complications. In addition, a multidisciplinary working group, which held discussions to establish the safe use of ESI, together with thirteen specialty stakeholder societies, issued 17 suggestions for the safe use of ESI.<su -Abstract Truncated-
clinical neurology